Stratos Wealth Partners LTD. Makes New $204,000 Investment in Doximity, Inc. $DOCS

Stratos Wealth Partners LTD. purchased a new stake in Doximity, Inc. (NASDAQ:DOCS) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 3,330 shares of the company’s stock, valued at approximately $204,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. VSM Wealth Advisory LLC purchased a new stake in shares of Doximity in the 1st quarter valued at about $29,000. Allworth Financial LP raised its holdings in shares of Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company’s stock valued at $32,000 after acquiring an additional 287 shares in the last quarter. National Bank of Canada FI purchased a new stake in shares of Doximity in the 1st quarter valued at about $33,000. Spire Wealth Management raised its holdings in shares of Doximity by 73.2% in the 1st quarter. Spire Wealth Management now owns 615 shares of the company’s stock valued at $36,000 after acquiring an additional 260 shares in the last quarter. Finally, Brooklyn Investment Group raised its holdings in shares of Doximity by 70.7% in the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company’s stock valued at $43,000 after acquiring an additional 309 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Price Performance

DOCS opened at $66.93 on Monday. The stock’s 50 day simple moving average is $69.60 and its 200 day simple moving average is $61.85. Doximity, Inc. has a 1 year low of $40.87 and a 1 year high of $85.21. The firm has a market cap of $12.54 billion, a price-to-earnings ratio of 66.93, a PEG ratio of 4.10 and a beta of 1.38.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter last year, the business posted $0.28 EPS. The company’s quarterly revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, sell-side analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current year.

Insider Buying and Selling

In other news, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction that occurred on Friday, October 10th. The stock was sold at an average price of $70.84, for a total value of $354,200.00. Following the sale, the director directly owned 19,839 shares in the company, valued at approximately $1,405,394.76. This trade represents a 20.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $57.09, for a total transaction of $114,180.00. Following the sale, the director directly owned 16,618 shares in the company, valued at $948,721.62. The trade was a 10.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 37,000 shares of company stock worth $2,635,880 in the last ninety days. 31.30% of the stock is owned by insiders.

Analysts Set New Price Targets

Several brokerages have recently commented on DOCS. Needham & Company LLC increased their price objective on Doximity from $67.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, August 8th. Truist Financial increased their price objective on Doximity from $52.00 to $61.00 and gave the company a “hold” rating in a research report on Thursday, July 17th. The Goldman Sachs Group set a $64.00 price objective on Doximity and gave the company a “sell” rating in a research report on Wednesday, October 1st. JPMorgan Chase & Co. reiterated an “underweight” rating and set a $62.00 price objective on shares of Doximity in a research report on Friday, October 10th. Finally, KeyCorp lifted their target price on shares of Doximity from $75.00 to $80.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, Doximity has an average rating of “Hold” and an average price target of $69.37.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.